Legend, a phase 1/2 study of detalimogene voraplasmid (eg-70) intravesical monotherapy demonstrated clinical responses in bcg-unresponsive nmibc patients with cis
Urologic Oncology: Seminars and Original Investigations（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要